A recent study focuses on developing low-cost techniques for detecting sickle cell disease and β-thalassemia. This research aims to identify carriers or those with the disease, particularly those with hemoglobin S (HbS) and other variants. The emphasis on low-cost detection methods highlights the need for accessible diagnostic tools, especially in resource-limited regions.
By developing such techniques, researchers hope to improve early detection and management of these conditions, potentially leading to better health outcomes. This approach aligns with broader efforts to enhance global health equity by making essential medical services more accessible to diverse populations (Shrestha et al., 2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
